Gutiérrez-Grobe Y - Search Results

1

High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity.

Gutiérrez-Grobe Y, Chávez-Tapia N, Sánchez-Valle V, Gavilanes-Espinar JG, Ponciano-Rodríguez G, Uribe M, Méndez-Sánchez N. Gutiérrez-Grobe Y, et al. Ann Hepatol. 2012 May-Jun;11(3):350-5. Ann Hepatol. 2012. PMID: 22481454 Free article.

2

Physical activity and nonalcoholic fatty liver disease.

Gutierrez-Grobe Y, Gavilanes-Espinar JG, Méndez-Sánchez N. Gutierrez-Grobe Y, et al. Ann Hepatol. 2009 Jul-Sep;8(3):273-4. Ann Hepatol. 2009. PMID: 19841513 Free article. No abstract available.

3

High ghrelin and obestatin levels and low risk of developing fatty liver.

Gutierrez-Grobe Y, Villalobos-Blasquez I, Sánchez-Lara K, Villa AR, Ponciano-Rodríguez G, Ramos MH, Chavez-Tapia NC, Uribe M, Méndez-Sánchez N. Gutierrez-Grobe Y, et al. Ann Hepatol. 2010 Jan-Mar;9(1):52-7. Ann Hepatol. 2010. PMID: 20308723 Free article.

4

Noninvasive markers of liver fibrosis in Latin America and Mexico.

Uribe M, Gutiérrez-Grobe Y, Kobashi-Margáin RA, Méndez-Sánchez N. Uribe M, et al. Ann Hepatol. 2010;9 Suppl:43-8. Ann Hepatol. 2010. PMID: 20713995 Free article. No abstract available.

5

Prevalence of type 2 diabetes mellitus and chronic liver disease: a retrospective study of the association of two increasingly common diseases in Mexico.

Kobashi-Margáin RA, Gutiérrez-Grobe Y, Ponciano-Rodríguez G, Uribe M, Méndez-Sánchez N. Kobashi-Margáin RA, et al. Ann Hepatol. 2010 Jul-Sep;9(3):282-8. Ann Hepatol. 2010. PMID: 20720269 Free article.

6

Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens.

Gutierrez-Grobe Y, Ponciano-Rodríguez G, Ramos MH, Uribe M, Méndez-Sánchez N. Gutierrez-Grobe Y, et al. Ann Hepatol. 2010 Oct-Dec;9(4):402-9. Ann Hepatol. 2010. PMID: 21057159 Free article.

7

Liver diseases in Mexico and their associated mortality trends from 2000 to 2007: A retrospective study of the nation and the federal states.

Méndez-Sánchez N, García-Villegas E, Merino-Zeferino B, Ochoa-Cruz S, Villa AR, Madrigal H, Kobashi-Margáin RA, Gutiérrez-Grobe Y, Chávez-Tapia N, Ponciano-Rodríguez G, Uribe M. Méndez-Sánchez N, et al. Ann Hepatol. 2010 Oct-Dec;9(4):428-38. Ann Hepatol. 2010. PMID: 21057162 Free article.

8

Albumin dialysis with molecular adsorbent recirculating system (MARS) for the treatment of hepatic encephalopathy in liver failure.

Kobashi-Margáin RA, Gavilanes-Espinar JG, Gutiérrez-Grobe Y, Gutiérrez-Jiménez AA, Chávez-Tapia N, Ponciano-Rodríguez G, Uribe M, Méndez Sánchez N. Kobashi-Margáin RA, et al. Ann Hepatol. 2011 Jun;10 Suppl 2:S70-6. Ann Hepatol. 2011. PMID: 22228886 Free article. Review.

9

Metabolic syndrome and nonalcoholic fatty liver disease. The role of endothelial progenitor cells.

Gutiérrez-Grobe Y, Gavilanes-Espinar JG, Masso-Rojas FA, Sánchez-Valle V, Páez-Arenas A, Ponciano-Rodríguez G, Chávez-Tapia NC, Uribe M, Méndez-Sánchez N. Gutiérrez-Grobe Y, et al. Ann Hepatol. 2013 Nov-Dec;12(6):908-14. Ann Hepatol. 2013. PMID: 24114821 Free article.

10

Less liver fibrosis in metabolically healthy compared with metabolically unhealthy obese patients with non-alcoholic fatty liver disease.

Gutiérrez-Grobe Y, Juárez-Hernández E, Sánchez-Jiménez BA, Uribe-Ramos MH, Ramos-Ostos MH, Uribe M, Chávez-Tapia NC. Gutiérrez-Grobe Y, et al. Diabetes Metab. 2017 Sep;43(4):332-337. doi: 10.1016/j.diabet.2017.02.007. Epub 2017 Mar 16. Diabetes Metab. 2017. PMID: 28318912 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page